Comparison of Antibody Confirmation Assays for Hepatitis C Virus Testing in Patients With HIV
All 3 antibody confirmation assays show comparable and high sensitivity in active HCV infections. Geenius potentially offers some advantages in ease of use, low turnaround time, and ruling out past infections. The added value of HCV antibody confirmation assays needs to be established in larger cost-effectiveness studies and is influenced by decreasing HCV prevalence and HCV RNA capacity.
Authors
- Kimcheng Choun
- Fien Vanroye (ORCID: https://orcid.org/0000-0002-7927-9221)
- Dorien Van den Bossche (ORCID: https://orcid.org/0000-0002-7545-4360)
- Koen Vercauteren (ORCID: https://orcid.org/0000-0003-1472-9938)
- Els Genbrugge (ORCID: https://orcid.org/0009-0000-9689-9804)
Institutions
- Research Institute for Tropical Medicine (PH)
- Sihanouk Hospital Center of HOPE (KH)
- Instituut voor Tropische Geneeskunde (BE)
Publication Details
- Journal
- Sexually Transmitted Diseases
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1097/olq.0000000000002205
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00